Celltrion's infliximab biosimilar to be tested for COVID-19
admin 16th June 2020 Uncategorised 0Infliximab has been chosen because of its effective role in treating autoimmune and inflammatory conditions and established safety profile
More: Celltrion's infliximab biosimilar to be tested for COVID-19
Source: News